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During 2014–2015, patients in northeastern Kenya were as-
sessed for brucellosis and characteristics that might help 
clinicians identify brucellosis. Among 146 confirmed brucel-
losis patients, 29 (20%) had negative serologic tests. No 
clinical feature was a good indicator of infection, which was 
associated with animal contact and drinking raw milk.
Brucellosis is a zoonotic disease that can cause severe illness in humans and substantial economic losses in 
livestock production (1). The main causative agents of bru-
cellosis in humans are Brucella abortus, B. melitensis, and 
B. suis (2). Infection in humans occurs mainly by ingestion 
of contaminated animal products, inhalation of contami-
nated airborne particulates, or direct contact with infected 
animals or their products (3). Clinical signs and symptoms 
of human brucellosis are nonspecific and highly variable 
(4). Persons who work with animals and their families are 
considered to be at high risk for infection (3,5). In animals, 
brucellosis is asymptomatic but can cause abortions, weak 
offspring, and sterility (5).
In developing countries, serologic assays based on 
rapid slide agglutination tests are the mainstay for diag-
nosis of brucellosis, but these assays have poor specific-
ity (6). Generally, ELISA is considered to be more spe-
cific and sensitive, allowing for a better correlation with 
the clinical situation. Although PCR assays are highly 
sensitive and specific tools for rapid diagnosis of 
human brucellosis and simultaneous differentiation of 
Brucella genotypes, they are often unavailable in many of 
these countries (7).
A review of brucellosis epidemiology in sub-Saharan 
Africa highlighted the fact that brucellosis is endemic in 
pastoral production systems where disease surveillance 
and control programs are poorly implemented (1). Within 
Kenya, seroprevalences of 2% and 7% have been reported 
among persons at high risk for brucellosis in Nairobi and 
Nakuru counties, respectively (8), and a national serop-
revalence of 3% was reported in 2007 (9). More recently, 
Osoro et al. (10) showed variation (2.4%–46.5%) in serop-
revalence across 3 counties in Kenya.
Diagnosis of febrile illnesses in developing countries 
is challenging because of the lack of imaging and reli-
able laboratory support. Clinical management of such ill-
nesses is often done empirically, resulting in inaccurate 
treatment of patients and routine underreporting of dis-
ease (11). Data on the prevalence and potential risk fac-
tors associated with human brucellosis in Kenya are scant. 
The prevalent Brucella species in Kenya remain largely 
unknown. The purposes of this study were to assess the 
proportion of patients with brucellosis at 2 hospitals in 
northeastern Kenya and to describe patient characteristics 
that might help clinicians to identify brucellosis cases in 
areas without laboratory support.
The Study
During 2014–2015, we enrolled patients with acute febrile 
illness seeking treatment at Garissa and Wajir hospitals in 
northeastern Kenya (Figure) by using systematic sampling 
intervals based on previously documented proportions of 
febrile patients recorded at each hospital. The study pro-
tocol was approved by the Scientific and Ethics Review 
Committee of Kenya Medical Research Institute. We ob-
tained serum samples and tested them for brucellosis by 
using the modified Rose Bengal Plate Test (RBPT) (VLA 
Weybridge, United Kingdom) (12) and SERION ELISA 
classic Brucella IgM/IgG kits (Virion/Serion, Wurzburg, 
Germany) according to the manufacturers’ instructions. 
We extracted DNA from serum samples by using the High 
Pure Template Kit (Roche Diagnostics, Mannheim, Ger-
many). We performed quantitative real-time PCR (qPCR) 
assays for the detection of brucellosis and speciation of 
Brucella species, as previously described (13) (online 
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Technical Appendix Table 1, http://wwwnc.cdc.gov/EID/
article/22/1/15-1200-Techapp1.pdf). We classified patients 
as having brucellosis if they had positive qPCR results or 
had positive RBPT results confirmed by positive ELISA 
results. We fitted multivariate logistic regression models 
to assess demographic, clinical features, and plausible risk 
factors associated with brucellosis seropositivity by using a 
stepwise backward analysis procedure.
Overall, 1,067 patients participated in the study; 580 
(54.4%) of participants were female, and 963 (90.3%) 
were of Somali ethnicity (online Technical Appendix Ta-
ble 2). Brucellosis was established in 146 patients (13.7%, 
95% CI 11.7%–15.9%). Of these, 29 (2.7%) had negative 
serologic test results for Brucella infection. B. abortus 
was the only Brucella species found using the Brucella 
species–specific qPCR.
Statistical analyses showed no significant differences 
in infection by ethnic group, county of residence, educa-
tion status, or age group. Men had a significantly higher 
probability (odds ratio [OR] 1.98, p = 0.001) for having 
brucellosis (Table 1).
Considerable low sensitivity levels were found for 
clinical diagnosis of brucellosis in both hospitals (online 
Technical Appendix Table 3). Patients with brucellosis 
were mainly diagnosed with typhoid fever (63 patients 
[43.2%]), malaria (30 [20.5%]), pneumonia (12 [8.2%]), 
and other common tropical fevers or fevers of unknown 
origin (14 [9.6%]) (Table 1).
In the final combined multivariate analyses, brucel-
losis was significantly associated (p<0.05) with fever 
lasting >14 days (adjusted OR [aOR] 2.86), contact with 
cattle (aOR 6.50) or multiple animal species (aOR 2.35), 
slaughtering of animals (aOR 2.20), and consumption of 
raw cattle milk (aOR 3.88). Herders were 1.69-fold more 
likely to be seropositive (Table 2).
Conclusions
This hospital-based study from a predominantly pastoral 
community in Kenya indicated a high prevalence (13.7%) 
of brucellosis in febrile patients, highlighting brucellosis as 
an important cause of acute febrile illnesses in northeastern 
Kenya. Although brucellosis has previously been described 
to occur in hospital patients in Kenya (1), it was not diag-
nosed by the treating hospital clinicians in 119/146 (81.5%) 
cases in our study. Instead, these cases were mainly attrib-
uted to other causes of fevers or fevers of unknown origin. 
In addition, 29 (2.7%) patients who had negative serologic 
test results for Brucella had positive results for B. abortus 
by qPCR. 
Our findings strongly suggest that patients with bru-
cellosis were likely to leave the hospital without the spe-
cific treatment for brucellosis. This agrees with recent 
findings that showed that clinicians in Kenya continue to 
treat febrile patients for presumptive malaria, resulting in 
missed opportunities to accurately detect and treat other 
causes of fever (11,14). The results also highlight the use-
fulness of qPCR as a complementary assay to a combined 
ELISA and RBPT diagnostic approach in diagnosis of 
acute brucellosis and the need to establish national and 
regional reference laboratories with facilities for perform-
ing qPCR assays.
Contact with cattle or multiple animal species and 
consumption of raw milk from cattle were significantly as-
sociated with brucellosis in our study (Table 2). This as-
sociation can be attributed to occupational and domestic 
contacts with livestock and social-cultural practices among 
communities in the study area that increase the risk for 
Brucella transmission, including nomadic movements, tak-
ing care of animals during parturition, consumption of raw 
milk from cattle and camels, and household slaughter of 
animals during traditional and religious ceremonies (9,15).
In this study, the only Brucella species detected was 
B. abortus, strengthening the assumption that brucellosis 
might be highly linked to cattle more than other animal spe-
cies; however, further research is warranted. Additionally, 
the prevalent Brucella genotypes and biovars in Kenya re-
main to be determined.
Figure. Locations of the 2 hospitals in the Northeastern Province 
of Kenya (dark gray shading) where human brucellosis was 
diagnosed in febrile patients seeking treatment, Kenya, 2014–
2015. The solid black area in northwestern Kenya represents 
disputed territory among Kenya, Ethiopia, and South Sudan. GPH, 
Garissa Provincial Hospital; WDH, Wajir District Hospital.
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Our study failed to better identify reliable clini-
cal predictors for brucellosis. The lack of a clear clini-
cal algorithm predictive of brucellosis supports the 
need for increasing clinician awareness of the disease 
and enhancing diagnostic capability for brucellosis in 
hospital settings.
This study has potential limitations. First, the study 
used acute-phase serum samples, making it difficult to 
demonstrate 4-fold titer rise. Follow-up of patients to ob-
tain a convalescent-phase serum sample was not feasible 
because of ongoing inter-clan conflicts and militia activi-
ties in the region. Therefore, the possibility of patients who 
had previous exposure to Brucella but had residual anti-
bodies in circulation cannot be ruled out.
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Table 1. Selected characteristics of study participants and number of febrile patients with Brucella-positive test results, northeastern 
Kenya, 2014–2015* 
Characteristic 
No. (%) patients 
p value Crude OR (95% CI) 
Positive for brucellosis, 
n = 146 
Negative for brucellosis, 
n = 921 
Mean age, y, + SD 34.8 + 11.5 33.9 + 12.6 0.863 NA 
Age group, y 
 <19 16 (11.0) 127 (13.8) NA Referent 
 20–29 31 (21.2) 206 (22.4) 0.418 1.29 (0.70–2.39) 
 30–39 48 (32.9) 265 (28.8) 0.063 1.75 (0.97–3.08) 
 40–49 38 (26.0) 196 (21.3) 0.169 1.52 (0.84–2.76) 
 >50 13 (8.9) 127 (13.8) 0.764 0.90 (0.43–1.84) 
Male sex 86 (58.9) 401 (43.5) 0.001 1.98 (1.30–2.68) 
Wajir County resident 81 (55.5) 440 (49.4) 0.201 1.34 (0.97–1.77) 
Occupation 
 Herder 109 (74.7) 569 (61.8) 0.002 3.81 (2.17–12.38) 
 Civil servant 16 (11.0) 126 (13.7) 0.199 2.53 (0.71–8.91) 
 General business 7 (4.8) 67 (7.3) 0.286 1.98 (0.49–7.85) 
 Student 6 (4.1) 56 (6.1) 0.308 2.08 (0.51–8.48) 
 Livestock trader 6 (4.1) 53 (5.8) 0.053 3.74 (0.98–14.26) 
 Other 2 (1.4) 50 (5.4) NA Referent 
Education level 
 None 98 (67.1) 563 (61.1) NA Referent 
 Primary 25 (17.1) 181 (19.7) 0.335 0.79 (0.51–1.27) 
 Secondary 16 (11.0) 104 (11.3) 0.670 0.88 (0.69–1.56) 
 Post-secondary 7 (4.8) 73 (7.9 0.146 0.56 (0.25–1.32) 
Somali ethnic group member 133 (91.1) 830 (90.1) 0.712 1.12 (0.62–2.63) 
Clinical symptoms and signs 
 Headache 113 (77.4) 836 (90.8) 0.504 1.45 (0.63–3.12) 
 Chills 93 (63.7) 482 (52.3) 0.065 1.79 (0.93–2.58) 
 Arthralgia/myalgia 118 (80.8) 699 (75.9) 0.322 1.48 (0.78–1.85) 
 Malaise/fatigue 101 (69.2) 646 (70.1) 0.018 2.20 (1.44–4.31) 
 Anorexia 63 (43.2) 514 (55.8) 0.610 0.91 (0.56–1.93) 
 Respiratory tract infection 34 (23.3) 263 (28.6) 0.434 1.03 (0.69–1.60) 
 Constipation 22 (15.1) 171 (18.6) 0.301 1.08 (0.83–3.11) 
 Night sweats 11 (7.5) 159 (17.3) 0.181 0.90 (0.67–5.90) 
 Diarrhea 8 (5.5) 106 (11.5) 0.120 0.95 (0.86–2.89) 
 Weight loss 12 (8.2) 105 (11.4) 0.228 1.24 (0.81- 6.04) 
 Confusion† 3 (2.3) 42 (5.3) 0.337 0.96 (0.60–2.91) 
 Rash 3 (2.1) 40 (4.3) 0.172 0.74 (0.22–1.55) 
 Vomiting 4 (2.7) 28 (3.0) 0.582 0.85 (0.36–1.98) 
 Abdominal pain 52 (35.6) 215 (23.3) 0.007 1.92 (1.35–5.64) 
 Hepatomegaly/splenomegaly 33 (22.6) 103 (11.1) 0.011 2.01 (1.63–8.10) 
 History of fever, >14 d 75 (51.4) 326 (35.3) <0.001 3.71 (2.75–10.94) 
Provisional diagnosis‡ 
 Typhoid fever 63 (43.2) 371 (45.0) 0.671 NA 
 Malaria 30 (20.5) 252 (30.5) 0.079 NA 
 Pneumonia 12 (8.2) 114 (13.8) 0.084 NA 
 Other§ 14 (9.6) Undefined NA NA 
Days since fever onset/median 24.5/16 13.0/8 <0.001 NA 
*NA, not available; OR, odds ratio. 
†Data available for adult and adolescent patients only. 
‡includes clinical diagnosis made by attending hospital clinician. 
§Data not available for all patients. 
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Table 2. Results of univariate and multivariate logistic regression analyses, by demographic, socioeconomic, and dietary risk factors 
associated with brucellosis, northeastern Kenya, 2014–2015* 
Characteristic 
No. (%) positive for 
brucellosis, n = 146 Crude OR (95% CI) Adjusted OR (95% CI)† p value 
Occupation 
 Herder 109 (16.1) 1.82 (1.22–2.71)‡ 1.69 (1.25–3.44) 0.023 
 Other 37 (9.5) Referent Referent NA 
History of fever, >14 d 
 Yes 75 (18.7) 3.71 (2.75–10.94)‡ 2.86 (1.91–6.74) 0.003 
 No 71 (10.7) Referent Referent NA 
Contact with goats§ 
 Yes 107 (15.5) 1.31 (0.87–2.29)¶ Referent  NA 
 No 38 (10.1) Referent NA  NA 
Contact with cattle 
 Yes 101 (21.7) 3.15 (2.84–4.87)‡ 6.50 (3.48–14.56) <0.001 
 No 45 (7.5) Referent NA  NA 
Contact with multiple animal species 
 Yes 78 (19.6) 2.59 (2.16–7.66)‡ 2.35 (2.14–8.63) 0.013 
 No 68 (10.2) Referent NA  NA 
Frequent slaughtering of animals 
 Yes 83 (21.7) 3.86 (3.21–5.69)‡ 2.20 (2.07–5.87) <0.001 
 No 63 (9.2) Referent Referent NA 
Frequent handling of raw milk 
 Yes 93 (15.8) 1.41 (0.75–2.15)¶ NA NA 
 No 53 (11.1) Referent Referent NA 
Frequent consumption of raw cattle milk 
 Yes 86 (26.0) 4.07 (2.39–9.55)‡ 3.88 (2.16–5.47) <0.001 
 No 60 (8.2) Referent Referent NA 
Frequent consumption of locally fermented milk products 
 Yes 72 (17.6) 1.68 (0.92–3.75)¶ NA NA 
 No 74 (11.2) Referent Referent NA 
Frequent consumption of raw goat milk 
 Yes 33 (17.9) 1.50 (0.98–2.95)¶ NA NA 
 No 113 (12.8) Referent Referent  NA 
Hosmer-Lemeshow goodness-of-fit test NA NA NA 0.228 
AUC (ROC) NA NA 0.745 (0.680–0.812) <0.001 
*AUC, area under the curve; NA, not available; OR, odds ratio; ROC, receiver operating characteristic. 
†Adjusted for age, sex, and site. 
‡p<0.05. 
§Contact with goats (referent variable in multivariable model). 
¶Variables with p<0.20 (Wald test) considered as potential risk and subsequently fitted in the multivariate analysis. 
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